نمایش پرونده ساده آیتم

Prevalence and clinical manifestations of constipation in children with cerebral palsy and comparison of the therapeutic effectiveness of polyethylene glycol with lactulose

dc.contributor.authorTaghizadeh Orangi , A
dc.date.accessioned2024-01-10T06:51:50Z
dc.date.available2024-01-10T06:51:50Z
dc.date.issued2023en_US
dc.identifier.urihttps://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/70052
dc.description.abstractCerebral palsy is the most common motor disability in childhood. Children with generalized cerebral palsy often suffer from comorbidities among which constipation is common. The prevalence of constipation in children with cerebral palsy depends on the definition of constipation, the diagnostic method, and how patients are selected. The treatment is associated with a lot of challenges and difficulties. The purpose of this study is to determine prevalence and clinical manifestations of constipation in children with cerebral palsy and to compare the therapeutic effectiveness of polyethylene glycol vs lactulose. Methodology and Materials: In this study, during a period of 12 months, all children aged 1-15 years with cerebral palsy who were referred to the outpatient clinic of Tabriz Children's hospital or the specialized clinic of Tabriz University of Medical Sciences after taking a detailed history in case of constipation criteria, entered the study. Diagnosing constipation based on clinical examination and according to Rome IV criteria was proposed by a pediatric gastroenterologist. The diagnosis of CP was made by a pediatric neurologist after a clinical and, if necessary, a paraclinical examination. After obtaining parental consent, the participants were divided into two groups, 1(PEG) and 2(lactulose). Results: A total of 48 patients (26 male, 54%) completed the study. A significant increase in defecation frequency and a significant decrease in encopresis frequency was found in both groups at 12 and 24 weeks of treatment. Success rate was significantly higher for PEG group (62%) compared to the lactulose group (37%). There were no serious adverse events recorded during the study. Patients receiving PEG reported less abdominal pain, bloating, nausea and vomiting. However, bad palatability and diarrhea were reported with more frequency in this group.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Medicineen_US
dc.relation.isversionofhttps://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/70051en_US
dc.subjectcerebral palsyen_US
dc.subjectconstipationen_US
dc.subjectlactuloseen_US
dc.subjectpolyethylene glycolen_US
dc.titlePrevalence and clinical manifestations of constipation in children with cerebral palsy and comparison of the therapeutic effectiveness of polyethylene glycol with lactuloseen_US
dc.titlePrevalence and clinical manifestations of constipation in children with cerebral palsy and comparison of the therapeutic effectiveness of polyethylene glycol with lactuloseen_US
dc.typeThesisen_US
dc.contributor.supervisorShoaran, M
dc.contributor.supervisorSadeghvand, Sh
dc.identifier.docno6011158en_US
dc.identifier.callno11158en_US
dc.description.disciplineMedicineen_US
dc.description.degreeMD Degreeen_US


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم